We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-9.94%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.23B
AUM Growth
-$302M
Cap. Flow
+$232M
Cap. Flow %
7.17%
Top 10 Hldgs %
15.77%
Holding
277
New
41
Increased
95
Reduced
109
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 33.24%
2 Healthcare 17.69%
3 Industrials 11.31%
4 Consumer Discretionary 8.04%
5 Financials 5.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MATV icon
101
Mativ Holdings
MATV
$711M
$11.6M 0.36%
338,011
-50,695
-13% -$1.85M
LRMR icon
102
Larimar Therapeutics
LRMR
$432M
$11.6M 0.36%
30,251
+3,067
+11% +$1.38M
APOG icon
103
Apogee Enterprises
APOG
$908M
$11.6M 0.36%
258,968
+93,756
+57% +$4.91M
EXAS
104
DELISTED
Exact Sciences
EXAS
$11.5M 0.36%
641,095
+272,600
+74% +$6.26M
MOD icon
105
Modine Manufacturing
MOD
$10.4B
$11M 0.34%
1,400,919
-20,405
-1% -$190K
TITN icon
106
Titan Machinery
TITN
$445M
$11M 0.34%
954,802
+920
+0.1% +$12.5K
CUBI icon
107
Customers Bancorp
CUBI
$2.77B
$10.7M 0.33%
418,200
+319,900
+325% +$8.13M
PFPT
108
DELISTED
Proofpoint, Inc.
PFPT
$10.7M 0.33%
176,795
-65,955
-27% -$4.1M
POWI icon
109
Power Integrations
POWI
$3.61B
$10.6M 0.33%
502,742
+107,200
+27% +$2.15M
AKRX
110
DELISTED
Akorn Inc
AKRX
$10.6M 0.33%
371,193
+276,393
+292% +$11.4M
INVN
111
DELISTED
Invensense Inc
INVN
$10.5M 0.33%
1,134,585
-78,900
-7% -$886K
NEO icon
112
NeoGenomics
NEO
$2.13B
$10.4M 0.32%
1,820,717
-120,212
-6% -$744K
FEIC
113
DELISTED
FEI COMPANY
FEIC
$10.4M 0.32%
142,822
+1,300
+0.9% +$102K
ADPT
114
DELISTED
Adeptus Health Inc
ADPT
$10.3M 0.32%
127,823
+66,433
+108% +$6.86M
EXAM
115
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$10.2M 0.32%
+349,800
New +$12.1M
LDRH
116
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$10.1M 0.31%
+292,632
New +$11.9M
FRPT icon
117
Freshpet
FRPT
$3.22B
$10M 0.31%
953,881
+487,092
+104% +$7.05M
RMTI icon
118
Rockwell Medical
RMTI
$28.2M
$9.95M 0.31%
11,729
+612
+6% +$887K
PRGS icon
119
Progress Software
PRGS
$1.76B
$9.81M 0.3%
380,000
COHR icon
120
Coherent
COHR
$74.2B
$9.69M 0.3%
602,666
-99,000
-14% -$1.71M
FNGN
121
DELISTED
Financial Engines, Inc.
FNGN
$9.5M 0.29%
+322,281
New +$12M
WAGE
122
DELISTED
WageWorks, Inc.
WAGE
$9.41M 0.29%
+208,700
New +$9.47M
YDLE
123
DELISTED
YODLEE INC COMMON STOCK
YDLE
$9.28M 0.29%
575,442
-56,189
-9% -$843K
LFUS icon
124
Littelfuse
LFUS
$11.6B
$9.12M 0.28%
100,000
-10,000
-9% -$911K
EXPO icon
125
Exponent
EXPO
$3.24B
$9.09M 0.28%
408,068
-104,600
-20% -$2.3M

Similar funds

Granahan Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Granahan Investment Management held 277 positions worth $3.23B, down 8.6% from $3.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management deployed $232M of net new capital in Q3 2015, opening 41 new positions and adding to 95 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 250,380 shares worth $33.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Bruker, an estimated $11.2M trimmed.

  • Granahan Investment Management's largest Q3 2015 buy was iShares Russell 2000 Growth ETF: 250,380 shares worth $33.5M.
  • Granahan Investment Management added most to DEMANDWARE INC COM STK (DE) in Q3 2015, an estimated $15.5M increase.
  • Granahan Investment Management's biggest Q3 2015 reduction was Bruker, cutting an estimated $11.2M.
  • Granahan Investment Management fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $24M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $3.23B portfolio in Q3 2015.
  • Granahan Investment Management opened 41 new positions and closed 22 in Q3 2015.
  • Granahan Investment Management's portfolio value fell 8.6% quarter-over-quarter to $3.23B.

Based on Granahan Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.